Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00369759 · ClinicalTrials.gov registry record
An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 2,048
- Enrollment target
NCT00369759: Completed study, sponsored by MedImmune.
NCT00369759 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 2,048 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00369759 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 2,048 participants
- Enrollment target
Study Summary
The primary objective of this study is to describe the incidence of RSV-associated LRI among infants \<1 year of age presenting to the ED during selected shoulder months.
Interventions
- OTHER Emergency Dept. Subjects with LRI or Apnea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,048 participants |
| Start Date | 2006-09 |
| Est. Completion | 2008-09 |
What the finished NCT00369759 record still lists
NCT00369759 is an observational study that tracks outcomes without assigning an intervention. Its 2,048 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Emergency Dept. Subjects with LRI or Apnea is the first listed.
NCT00369759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00369759 about?
NCT00369759 is a clinical study titled "An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants". The primary objective of this study is to describe the incidence of RSV-associated LRI among infants \<1 year of age presenting to the ED during selected shoulder months.
What is the current status of trial NCT00369759?
This trial is currently completed. The enrollment target is 2,048 participants. The study started on 2006-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00369759?
The interventions under investigation include: Emergency Dept. Subjects with LRI or Apnea (OTHER).
Who is sponsoring clinical trial NCT00369759?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia